News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Cell Technology Announces 2013 Third Quarter Results



11/13/2013 10:17:45 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Advanced Cell Technology, Inc. (“ACT”; OTC:ACTC or the “Company”), a leader in the field of regenerative medicine, announced today third quarter financial results for the period ended September 30, 2013 and provided an update on their clinical and pre-clinical programs.

Highlights from the third quarter include:

•Received Data Safety Monitoring Board (“DSMB”) Approval to complete the third cohort, which entails finishing the enrollment and treatment of the remaining two patients, in each of the Company’s three ongoing clinical trials with the higher dosage of retinal pigment epithelial (“RPE”) cells derived from human embryonic stem cells (hESCs).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES